GENELUX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.71 USD | +2.26% |
|
+3.44% | -80.66% |
| 05-24 | Top Midday Decliners | MT |
| 05-24 | Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop | MT |
Chart calendar Genelux Corporation
ef94a1c5c093304a585eb.9KtAt6aItbEUpHFT_Ut-VtPed6t1yRfhV9Lu0EP6k9I.me8I3Orrw99h_jgMjg8aYYmnMsEBmW6vHJ-s_QGq1JfH_wnF37_Bx2DVHg~89c3f149bd60cc7cbc233fe6604bdd67
Upcoming events on Genelux Corporation
Past events on Genelux Corporation
| 20/05/2024 | Benchmark Healthcare House Virtual Conference |
| 09/05/2024 21:25 | Q1 2024 Earnings Release |
| 01/04/2024 12:00 | Q4 2023 Earnings Release |
| 14/11/2023 22:50 | Q3 2023 Earnings Release |
| 11/09/2023 05:00 | H.C. Wainwright Global Investment Conference |
| 10/09/2023 | Annual General Meeting |
| 14/08/2023 12:00 | Q2 2023 Earnings Release |
| 08/08/2023 21:00 | BTIG’s Virtual Biotechnology Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 11,1 11,0 0.62% | 0,17 0,18 -4.23% | 0,01 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -3,01 -3,42 11.87% | -24,2 -22,1 -9.2% | -25,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -4,11 -4,11 0.12% | -28,3 -26,3 -7.44% | -27,3 |
|
Net income Million USD | Released Forecast Spread | -16,4 | -5,21 -5,21 0.1% | -28,3 -26,3 -7.44% | -27,3 |
|
EPS USD | Released Forecast Spread | -0,60 | -0,21 -0,28 25% | -1,16 -1,09 -6.75% | -0,96 |
| Announcement Date | 24/06/22 | 29/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,17 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,01 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,46 -3,70 -74.65% | -5,40 -3,35 -61.04% | -5,31 -4,09 -29.79% | -7,00 -4,96 -41.28% | -8,12 -5,66 -43.39% | -5,83 | -6,02 | -6,20 | -7,03 | -6,10 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,4 -3,70 -180.11% | -5,82 -3,35 -73.76% | -5,35 -4,09 -30.72% | -6,77 -4,81 -40.76% | -7,85 -6,12 -28.29% | -6,51 | -6,63 | -6,79 | -7,03 | -6,10 |
|
Net income Million USD | Released Forecast Spread | -10,4 -3,70 -180.11% | -5,82 -3,35 -73.76% | -5,35 -4,09 -30.72% | -6,77 -4,81 -40.76% | -7,85 -6,12 -28.29% | -6,51 | -6,63 | -6,79 | -7,03 | -6,10 |
|
EPS USD | Released Forecast Spread | -0,53 -0,16 -231.25% | -0,23 -0,16 -48.39% | -0,20 -0,18 -13.21% | -0,25 -0,18 -38.89% | -0,29 -0,23 -26.09% | -0,24 | -0,22 | -0,23 | -0,21 | -0,18 |
| Announcement Date | 15/05/23 | 14/08/23 | 14/11/23 | 29/03/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Genelux Corporation
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 13:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GNLX Stock
- Calendar Genelux Corporation
